Charles River Laboratories International, Inc.
CRLNYSEHealthcare● Active
$181.34
$-4.45(-2.40%)
Market Cap$8.7B
P/E Ratio—
52W High$228.88
52W Low$140.78
Charles River Laboratories International, Inc.（CRL）股票价格历史
关键价位里程碑、OHLCV 表、年度回报、同业与 What If。
crl · 日线历史（复权）· FMP · 截至 2026年6月5日
5-Year High5Y
$460.21
Sep 24, 2021
-60.6% from here
5-Year Low5Y
$91.86
Apr 11, 2025
+97.4% from low
IPO Priceadj.
$22.00
Jun 23, 2000
+724.3% since IPO
1 Year Ago
$147.46
Jun 9, 2025
+23.0% in 1Y
5 Years Ago
$343.02
Jun 8, 2021
-47.1% in 5Y
10 Years Ago
$85.72
Jun 8, 2016
+111.5% in 10Y
Historical Price Data · CRL
| Date↓ | Open↕ | High↕ | Low↕ | Close↕ | Close (Unadj.) ⓘ | Volume↕ | Change %↕ |
|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | $187.18 | $187.35 | $180.55 | $181.34 | $181.34 | 519K | -3.12% |
| Jun 4, 2026 | $182.00 | $187.95 | $180.60 | $185.79 | $185.79 | 737K | +2.08% |
| Jun 3, 2026 | $172.75 | $181.05 | $169.46 | $179.87 | $179.87 | 536K | +4.12% |
| Jun 2, 2026 | $179.00 | $181.76 | $172.17 | $174.79 | $174.79 | 752K | -2.35% |
| Jun 1, 2026 | $180.28 | $184.68 | $178.06 | $182.07 | $182.07 | 996K | +0.99% |
| May 29, 2026 | $181.34 | $184.83 | $177.01 | $180.71 | $180.71 | 1.0M | -0.35% |
| May 28, 2026 | $163.98 | $183.80 | $163.98 | $181.34 | $181.34 | 1.3M | +10.59% |
| May 27, 2026 | $157.87 | $164.77 | $157.87 | $164.49 | $164.49 | 1.2M | +4.19% |
| May 26, 2026 | $160.54 | $160.54 | $155.50 | $156.73 | $156.73 | 1.1M | -2.37% |
| May 22, 2026 | $159.83 | $163.42 | $155.56 | $160.30 | $160.30 | 589K | +0.29% |
| May 21, 2026 | $155.06 | $160.66 | $153.11 | $158.86 | $158.86 | 868K | +2.45% |
| May 20, 2026 | $152.81 | $157.04 | $147.51 | $156.03 | $156.03 | 881K | +2.11% |
| May 19, 2026 | $150.59 | $154.40 | $146.20 | $152.43 | $152.43 | 1.1M | +1.22% |
| May 18, 2026 | $152.20 | $157.54 | $149.42 | $149.93 | $149.93 | 1.6M | -1.49% |
| May 15, 2026 | $157.54 | $160.26 | $149.98 | $150.85 | $150.85 | 1.4M | -4.25% |
| May 14, 2026 | $163.91 | $164.37 | $158.89 | $159.12 | $159.12 | 829K | -2.92% |
| May 13, 2026 | $167.04 | $167.04 | $160.08 | $162.85 | $162.85 | 735K | -2.51% |
| May 12, 2026 | $169.23 | $171.02 | $163.45 | $168.69 | $168.69 | 725K | -0.32% |
| May 11, 2026 | $176.97 | $178.41 | $168.44 | $168.46 | $168.46 | 762K | -4.81% |
| May 8, 2026 | $182.56 | $183.65 | $174.07 | $177.62 | $177.62 | 978K | -2.71% |
Showing 1–20 of 1,254 records
Annual Stock Price Performance · CRL
Jan 1 → Dec 31 · 6 years2026-9.4%$200.13 → $181.34
-9.4%
2025+6.7%$186.92 → $199.48
+6.7%
2024-21.3%$234.56 → $184.60
-21.3%
2023+7.3%$220.32 → $236.40
+7.3%
2022-42.1%$376.61 → $217.90
-42.1%
2021+9.2%$345.00 → $376.78
+9.2%
Best Year2021 · +9.2%
Worst Year2022 · -42.1%
Positive Years3 / 6
Avg Annual Return-8.3%
6Y Total Return-47.4%
6Y CAGR~-10.2% / yr
Similar Companies in Healthcare
View sector
Eli Lilly and Company
LLY.TO
$40.68+0.00%
Mkt Cap $1.40T
Eli Lilly and Company
LLY
$1,131.42+0.00%
Mkt Cap $1.07T
Johnson & Johnson
JNJ
$232.77+0.00%
Mkt Cap $560.3B
AbbVie Inc.
ABBV
$227.23+0.00%
Mkt Cap $401.5B
UnitedHealth Group Incorporated
UNH
$399.47+0.00%
Mkt Cap $362.8B
Merck & Co., Inc.
MRK
$120.79+0.00%
Mkt Cap $298.3B
AstraZeneca PLC
AZN
$185.95+0.00%
Mkt Cap $288.4B
Novartis AG
NVS
$149.16+0.00%
Mkt Cap $284.6B
Novo Nordisk A/S
NVO
$42.96+0.00%
Mkt Cap $190.9B
Amgen Inc.
AMGN
$349.58+0.00%
Mkt Cap $188.7BWhat If You Invested in CRL?
If you invested $1,000 in CRL 10 years ago — how much would it be worth today?
INVESTED$1,000
→TODAY WORTH$2,115
Total Return+111.5%
CAGR~+7.8% / yr
Profit+$1,115
Based on Jun 8, 2016 · $85.72Split & dividend adjustedNo fees assumed
Want a detailed breakdown?
Try the full calculator with custom amounts, dates & DRIP.
Full Calculator →Try the full calculator with custom amounts, dates & DRIP.
关于价格历史与 OHLCV 数据
Charles River Laboratories International, Inc.（CRL）所属板块为 Healthcare，主要交易场所为 NYSE。本页行情快照中的最近价为 $181.34。下方的图表与 OHLCV 表可查看历史开高低收与成交量。
年度表现条、同行业相似公司，以及 What If 假设计算器，便于在同一页面对比中长期收益。价格在注明处为拆股等调整后的日线数据；本页内容仅供信息参考，不构成投资建议。
数据：FMP 日线收盘 · 注明处为拆股等调整价 · 不构成投资建议
常见问题
CRL 价格历史 · 5 个问题日线数据来自市场数据商（Financial Modeling Prep）。拆股等公司行为可能体现在复权序列中；重要决策请以券商或官方披露为准。
CRL 历史股价FMP 日线复权 OHLCV